C4 Therapeutics, Inc.
CCCC
$2.62
-$0.20-6.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 191.88M | 214.55M | 215.09M | 244.90M | 255.64M |
| Total Receivables | 6.54M | 2.16M | 8.03M | 3.10M | 10.34M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.44M | 8.02M | 9.42M | 9.76M | 7.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 206.86M | 224.73M | 232.54M | 257.77M | 273.23M |
|
|
|||||
| Total Current Assets | 206.86M | 224.73M | 232.54M | 257.77M | 273.23M |
| Net Property, Plant & Equipment | 47.10M | 59.76M | 61.36M | 63.38M | 65.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.65M | 3.62M | 6.01M | 6.10M | 8.70M |
| Total Assets | 265.49M | 296.53M | 319.52M | 349.60M | 376.06M |
|
|
|||||
| Total Accounts Payable | 1.33M | 2.22M | 683.00K | 1.33M | 1.50M |
| Total Accrued Expenses | 9.52M | 11.98M | 10.75M | 17.49M | 13.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.22M | 6.07M | 5.92M | 5.77M | 5.63M |
| Total Finance Division Other Current Liabilities | 18.88M | 24.20M | 23.47M | 20.58M | 22.59M |
| Total Other Current Liabilities | 18.88M | 24.20M | 23.47M | 20.58M | 22.59M |
| Total Current Liabilities | 35.95M | 44.46M | 40.82M | 45.18M | 43.29M |
|
|
|||||
| Total Current Liabilities | 35.95M | 44.46M | 40.82M | 45.18M | 43.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.25M | 56.86M | 58.45M | 59.98M | 61.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.89M | 21.15M | 25.12M | 28.46M | 28.65M |
| Total Liabilities | 111.08M | 122.46M | 124.38M | 133.62M | 133.40M |
|
|
|||||
| Common Stock & APIC | 872.53M | 860.14M | 855.12M | 849.63M | 841.33M |
| Retained Earnings | -718.21M | -686.04M | -660.02M | -633.70M | -599.13M |
| Treasury Stock & Other | 87.00K | -30.00K | 43.00K | 53.00K | 455.00K |
| Total Common Equity | 154.41M | 174.06M | 195.14M | 215.99M | 242.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 154.41M | 174.06M | 195.14M | 215.99M | 242.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 154.41M | 174.06M | 195.14M | 215.99M | 242.66M |
|
|
|||||